Liminatus Pharma, Inc. Class A Common Stock (LIMN) — Financial Flexibility Index
Liminatus Pharma, Inc. Class A Common Stock (LIMN) has a Financial Flexibility Index of -0.69x as of March 2026. Free cash flow of $-2.02 Million (operating CF $-2.02 Million minus capex $0.00) represents -1% of total liabilities ($2.92 Million). Check LIMN tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Liminatus Pharma, Inc. Class A Common Stock Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for Liminatus Pharma, Inc. Class A Common Stock across 5 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Liminatus Pharma, Inc. Class A Common St.
Annual Financial Flexibility Index for Liminatus Pharma, Inc. Class A Common Stock (2021–2025)
Year-by-year free cash flow to debt coverage for Liminatus Pharma, Inc. Class A Common Stock. Explore LIMN cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.96x | $-9.95 Million | $-9.96 Million | $10.33 Million | ▼ -479.9% |
| 2024 | -0.17x | $-3.11 Million | $-3.11 Million | $18.70 Million | ▲ +24.5% |
| 2023 | -0.22x | $-3.35 Million | $-3.35 Million | $15.19 Million | ▼ -259.6% |
| 2022 | -0.06x | $-869.00K | $-869.00K | $14.19 Million | ▼ -8.6% |
| 2021 | -0.06x | $-1.22 Million | $-1.22 Million | $21.57 Million | — |